Marshall Wace North America’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-63,084
| Closed | -$1.94M | – | 1646 |
|
|
2021
Q2 | $1.94M | Buy |
+63,084
| New | +$1.94M | 0.01% | 797 |
|
|
2020
Q4 | – | Sell |
-42,185
| Closed | -$880K | – | 1566 |
|
|
2020
Q3 | $880K | Sell |
42,185
-81,547
| -66% | -$1.7M | 0.01% | 836 |
|
|
2020
Q2 | $2.94M | Buy |
123,732
+97,769
| +377% | +$2.32M | 0.02% | 481 |
|
|
2020
Q1 | $468K | Sell |
25,963
-30,477
| -54% | -$549K | ﹤0.01% | 768 |
|
|
2019
Q4 | $1.34M | Sell |
56,440
-460,203
| -89% | -$10.9M | 0.01% | 664 |
|
|
2019
Q3 | $14.2M | Buy |
516,643
+14,860
| +3% | +$408K | 0.08% | 207 |
|
|
2019
Q2 | $16.6M | Buy |
501,783
+275,490
| +122% | +$9.12M | 0.1% | 170 |
|
|
2019
Q1 | $7.93M | Buy |
226,293
+60,880
| +37% | +$2.13M | 0.06% | 242 |
|
|
2018
Q4 | $5.5M | Buy |
+165,413
| New | +$5.5M | 0.05% | 238 |
|
|
2018
Q2 | – | Sell |
-79,058
| Closed | -$3.62M | – | 1666 |
|
|
2018
Q1 | $3.62M | Buy |
79,058
+46,318
| +141% | +$2.12M | 0.02% | 644 |
|
|
2017
Q4 | $1.31M | Buy |
+32,740
| New | +$1.31M | 0.01% | 938 |
|
|
2017
Q2 | – | Sell |
-15,101
| Closed | -$468K | – | 1453 |
|
|
2017
Q1 | $468K | Buy |
+15,101
| New | +$468K | ﹤0.01% | 824 |
|